The National Institutes of Health (NIH) is offering a funding opportunity for Small Business Innovation Research (SBIR) applications aimed at the development of medications to treat Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD). Eligible applicants, primarily small businesses, must propose therapeutic candidates with established preclinical data, ready for transition to clinical development, with projects permissible at various stages of the drug development continuum. This initiative is critical for advancing new therapies towards FDA approval, with funding limits of up to $1 million per year for Phase I (U43) and $1.5 million for Phase II (U44) applications. Interested parties should note that the application deadline is December 4, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.